CA-MIRO
28.4.2022 13:02:12 CEST | Business Wire | Press release
Miro , the online platform accelerating innovation through visual collaboration, today announced Miro Next , an all-virtual event revealing the next big thing for hybrid teams through the latest product and partner developments from the company. Miro Next will take place on May 18, 2022, at 8am PST / 5pm CEST and is purposefully designed to empower global teams to do more together.
Everyone is looking for new ways to succeed and thrive in today’s hybrid work environments. Some of the secrets to success include meetings that are more inclusive and interactive – blurring the lines between in-person and the virtual experience. Companies will need custom integrations between critical applications to help drive productivity and simplify the user experience, and more and more organizations will adopt agile practices that increase teamwork and speed innovation. Miro Next will explore these strategies, along with a host of updates on product features and enhancements, all designed to help organizations make hybrid work.
The event will kick off with a keynote presentation by Varun Parmar, Miro’s Chief Product Officer. Joined onstage with Miro partners and featured speakers, including Jeetu Patel of Cisco and Megan Cook of Atlassian, Parmar will show how Miro’s digital whiteboard is just the beginning of the future of visual collaboration.
“Miro Next will help us rediscover how to put people at the center of hybrid work, and in doing so, drive deeper engagement and collaboration among teams,” said Parmar. “I hope that teams all around the world will join us for this one-of-a-kind experience in just a few weeks.”
Miro Next will also feature a presentation led by Thor Mitchell, Miro’s Head of Product, Developer Platform, giving attendees an up-close-and-personal look at the next generation of Miro’s Developer Platform, and why it’s the perfect product to create an integrated collaboration experience that’s quick, easy, and seamless. The Miro Developer Platform was created three years ago to give any individual or enterprise the ability to build plugins and third-party integrations, and embed live Miro boards into other apps using Miro’s open API and SDKs. The Miro Developer Platform unlocks new, custom workflows to enhance the collaborative experience. At Miro Next, Airtable, ClickUp and others will join Mitchell to show how the Miro Developer Platform has unlocked new ways to harness visual collaboration using Miro and what they’re planning in the future.
In addition to learning about the future of visual collaboration from Miro product leaders and partners, Miro Next attendees will get exclusive access to breakout sessions to share ideas, ask questions, and connect with other Miro users who are seeking new ways to co-create with their teams, both synchronously and asynchronously. Miro Next breakout sessions include:
- The Road to Accessibility: A Collaborative Journey - Join Phil Strain, Miro Lead Product Manager for Accessibility and Design, and Sheri Byrne-Haber, VMWare Senior Staff Architect for Accessibility, to explore how an inclusive mindset can be a game-changer when it comes to company and end-user engagement.
- The Hybrid Workplace: Securing and Managing Collaboration In This New Way of Working - This thought leadership panel will include industry experts from Miro, Netskope, and Onna, sharing their top insights and practices for securing and managing hybrid workforces, while creating frictionless environments that help drive collaboration and creativity.
- Connected and Aligned: Your Hybrid Team in Miro - Join Miro’s team of customer education experts to learn how to use Miro features and skills to include all voices in collaborative work and create a one-stop Miro board for teams to gather information, share resources, and align expeditiously on what’s most important.
Miro Next will help all teams jump from “what now?” to “what’s next?” and explore their collaborative potential. Be among the first to preview new Miro features and get a sneak peek into the modern visual collaboration ecosystem:
- WHEN : May 18, 2022, 8 am PT/ 5 pm CET
- WHAT : One highlight-filled keynote session (60 minutes) and three, exclusive breakout sessions (60 minutes each)
- HOW : It’s virtual! RSVP for free at miro.com/next
About Miro
Miro is an online, visual collaboration platform designed to unlock creativity and accelerate innovation among teams of all kinds. The platform’s infinite canvas enables teams to lead engaging workshops and meetings, design products, brainstorm ideas, and more. Miro, co-headquartered in San Francisco and Amsterdam, serves more than 30M users worldwide, including 99% of the Fortune 100. Miro was founded in 2011 and currently has more than 1,400 employees in 10 hubs around the world. To learn more, please visit https://miro.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220428005447/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom